Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Modul-Bio is a French life science software company focused on informatics and traceability solutions for biobanks, biological resource centers, cohort studies, research centers, and related diagnostic and biotechnology users. Founded in 2003 and headquartered in Marseille, the company develops commercial products including MBioLIMS BioBanking for biospecimen lifecycle and data management, MBioLABEL for barcode-based sample identification and traceability, and eMBioBANK for web-based publication and sharing of biospecimen collections. Its offerings are used to manage sample reception, processing, storage, genealogy, shipment, and associated data across single-site and multi-site environments. In December 2025, Modul-Bio was acquired by Comet Software, with management reported to remain in place.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Modul-Bio.